Animalcare Share Discussion Threads

[3800] 18/4/2018 07:32

What a disaster this has been for shareholders! I'm glad I sold out last June. I am not sure what price (if any) it would be good value to buy back again.
3800

[trident5] 13/10/2017 15:29

Second that

[lanzarote666] 20/8/2017 09:41

Coverage in the Mail on Sunday today.

[trident5] 26/6/2017 22:07

Maybe - it's their acquisition philosophy that's the killer for me.Pity ANCR looked a good long term hold.

[mw8156] 26/6/2017 21:51

might expect now that Ecuphar is a public co, margins might improve hopefully as the Directors take less out and there might be some synergies to be realised with Animalcare?

[trident5] 26/6/2017 20:48

MW - I think it's a bad deal because:

- they've paid a very hefty multiple;
- there's no demonstrable evidence that the acquired company is growing organically - it will continue on an acquisition spree, the admission document is clear about that - these really end well;
- there's now quite a lot of debt on the balance sheet;
- margins are very thin; and
- it's not clear why Animalcare have done this.

[mw8156] 26/6/2017 20:39

too early to say whether it will be bad for holders; could reach such a conclusion may be in a year or two
am disappointed that Ecuphar has obtained a lot of goodies without paying eg a listing on the stock market and effectively taken over ANCR without paying any sort of premium

[3800] 26/6/2017 19:39

I've sold out too, it's an unbelevably bad deal for shareholders. 3800

[cisk] 26/6/2017 14:23

I'm out too. It's been a great share but I don't think this deal adds up. I don't like how it's being rushed through - why? Why the massive urgency to buy an unquoted company? I don't like how control is effectively being given to two people I've never heard of. I don't like how they have gone from being in a profitable niche to what seems like massively overpaying for a reverse takeover. And I don't like how private shareholders were locked out of a placing at a large discount. And I don't like how a significant cash balance has been turned into debt (if I read it correctly).

It's a shame because it was a great company and I thought had more promise to come. Best of luck to remaining holders.

[hydrus] 26/6/2017 11:32

Ecuphar have much lower profit margins. I am struggling with this one. They are paying £135m for a company earning £3.5m, so PE of around 38.I've decided to sell out as this is a completely different proposition now. Might work out well but happy to watch from sidelines for now.

[3800] 26/6/2017 11:31

got an email to say trading had recommenced, down 20p so it could have been worse, not best pleased but not expecting the management to be interested. 3800

[trident5] 25/6/2017 10:18

I'm presuming that this is a move to avoid the consequences of Brexit.

[3800] 23/6/2017 08:26

Thanks for doing the maths on that one nfs, not that we can sell up at the moment anyway, I'm not sure if the larger group will enjoy a higher rating but it hardly looks like a bonanza for existing shareholders.
3800

[nfs] 23/6/2017 08:14

It's 8.6m shares to raise not less than £30m so implying a price of approx £3.49

[essential] 23/6/2017 08:00

Let's wait and see - I personally was looking at the positives i.e. Step change in size and profits with multiple new cross selling opportunities. Although this won't mean much if the share price drops 30% on relisting

[cisk] 23/6/2017 07:32

Nfs, no share price reaction as they are suspended this morning.

Personally, I want to understand more why they are doing this deal (as opposed to continuing to grow organically) and does anyone know what the placing price is? I believe it's not set yet, if it turns out to be any lower than the current market price pre-suspension the private investors, i.e. us, are shafted as we cannot participate in the placing. This is quite disgusting as it's a huge placing of 40% of the company.

I wonder how many shares are in PI hands?

[hydrus] 23/6/2017 07:24

Ecuphar is a private company and I can't find accounts for it. Just have to wait for more information. Their board is basically taking over the ANCR board and the Ecuphar guys will own almost 50% of the business. We are actually now investors in Ecuphar in reality.

[nfs] 23/6/2017 07:14

Yes wow is the word. Not sure what the share price acting n is going to be today

[hydrus] 23/6/2017 07:06

Blimey ANCR had revenue of £15m last year, Ecuphar £68m. This is going to be on quite a different scale going forward, and a very different company. Most definitely a reverse takeover!

[3800] 17/3/2017 14:36

10% price surge from 420 to 460 to buy today, has this share been tipped somewhere?

[thorpematt] 07/3/2017 14:22

Well these have been a tad tricky to but of late!

Never mind, now i have finished loading up the price will no doubt re-trace heavily and provide better opportunities. I certainly liked the narrative of expanding oversees sales and my previous note to self which read something along the lines of "a tad expensive" were rather thrown in the bin.

[hopefuldave] 06/3/2017 23:53

Well, I'm pleased as a new investor.questionis, take profits or stick.?.